💣 Big Pharma’s Antivirals Are a Complete FAILURE! 💣
BREAKING NEWS! The so-called “trusted” RECOVERY Collaborative group, led by Sir Peter Horby at the University of Oxford, has exposed the ugly truth Big Pharma doesn’t want you to know! Both Pfizer’s Paxlovid and Merck’s Molnupiravir are utter failures when it comes to protecting hospitalized COVID-19 patients. 🚨💊
Despite all the hype and relentless pushing by the corrupt medical establishment, these antivirals did NOTHING to reduce mortality, shorten hospital stays, or prevent the need for invasive mechanical ventilation. That’s right, folks, they were useless! 🛑💉
The Real Findings 🔍:
The RECOVERY Collaborative group, influential during the COVID-19 pandemic, conducted trials involving nearly 50,000 participants across 189 sites. This powerhouse team has previously identified four life-saving treatments for COVID-19. However, their recent findings on antivirals show that neither Paxlovid nor Molnupiravir could make a significant difference in the outcomes for hospitalized COVID-19 patients. The trials collected data from January 24, 2022, to May 24, 2023, for Molnupiravir, involving 923 patients, and from March 31, 2022, to May 24, 2023, for Paxlovid, involving 137 patients.
Over 75% of the patients were vaccinated, and many were receiving other antivirals like remdesivir or sotrovimab. Despite these measures, the study revealed no improvement in the patients’ conditions. For instance, 74 (17%) of the patients in the Molnupiravir group and 79 (17%) in the usual care group died within 28 days (HR 0.93; 95% CI 0.68-1.28; p=0.66). Similarly, 13 (19%) patients in both the Paxlovid group and the usual care group died within 28 days (HR 1.02; 95% CI 0.47-2.23; p=0.96).
The Bombshell Findings 📢:
These findings are not only disappointing but also alarming, considering the significant resources and hopes placed on these antivirals. The RECOVERY investigators highlighted that neither Molnupiravir nor Paxlovid reduced the duration of hospitalization or prevented the progression to invasive ventilation or death. This lack of efficacy is a huge letdown, given the initial promises made by Big Pharma.
The study’s limitations, such as the lack of peer review and limited statistical power due to low recruitment numbers, do not overshadow the grim reality: these expensive drugs, touted as life-savers, did not deliver. The continuous push of such treatments raises serious questions about the integrity and priorities of those involved in the pandemic response.
The Cover-Up 🕵️♂️🔍:
Big Pharma and the government are in cahoots to push these ineffective, dangerous drugs on the public while covering up their failures. They want you to believe in these miracle cures while hiding the truth that they are useless and part of a larger agenda to control and harm us. 💉💀
The media, as always, plays its part in this grand deception. They will not highlight these failures, instead choosing to focus on the so-called “success stories” and the importance of vaccination and pharmaceutical interventions. This is all part of the plan to keep the public in the dark and dependent on these corporations for their health and safety. It’s a cycle of fear and misinformation designed to keep us compliant and unaware of the true dangers we face.
Wake Up, People! 🗣️
We need to spread the word and expose these lies. Trusting Big Pharma and the government with our health is a deadly mistake. 🚨
The reality is clear: Paxlovid and Molnupiravir are not the miracle cures they were made out to be. Instead, they represent a dangerous trend of prioritizing profit over patient health. The findings from the RECOVERY Collaborative group should be a wake-up call for everyone. We must question the narratives fed to us and seek out the truth for ourselves.
Read the full article here: TrialSiteNews
Here are six current articles discussing the failure of Pfizer’s Paxlovid and Merck’s Molnupiravir in protecting hospitalized COVID-19 patients:
- Newsweek: This article compares the efficacy of Paxlovid and Molnupiravir, highlighting that neither drug significantly reduced hospitalization or mortality rates among COVID-19 patients. It emphasizes the disappointment given the high expectations set by earlier trials.
Read more - MedPage Today: A comprehensive study reveals that Paxlovid and Molnupiravir did not show significant benefits for hospitalized COVID-19 patients, particularly during the Omicron variant wave. The article discusses ongoing research and the need for further data to validate the findings.
Read more - eLife: This retrospective cohort study from Hong Kong analyzes the effectiveness of Paxlovid in hospitalized patients, concluding that while antiviral treatments have potential, they did not significantly reduce severe outcomes or mortality in the study population.
Read more - Springer: This literature review examines real-world evidence on Molnupiravir’s effectiveness, indicating mixed results and highlighting the necessity for more robust data to assess its true impact on hospitalized COVID-19 patients.
Read more - Oxford Academic: This academic article delves into the real-world effectiveness of nirmatrelvir/ritonavir and Molnupiravir, noting that both drugs had limited impact on hospitalized patients with COVID-19, emphasizing the need for alternative treatment strategies.
Read more - Pfizer News: Despite promising early results, this article highlights that recent data shows Paxlovid did not significantly improve outcomes in standard-risk patients, leading to a halt in certain trial enrollments and a focus on vulnerable populations.
Read more
These articles provide a thorough overview of the current understanding and ongoing research into the effectiveness of Paxlovid and Molnupiravir in treating hospitalized COVID-19 patients.
- Another Unstoppable Monkey Virus With No Cure Infecting Humans 🐵🔒Unleashing Synthetic Biogenesis: The Final Phase of the Pandemic Agenda In the latest chapter of global health manipulation, reports are surfacing of a “new” virus sweeping through Europe, with no cure in sight. But what they’re not telling you is that this is no natural virus—it’s a product of synthetic biology, lying dormant in those who received the COVID-19 injection. Imagine a world where frequency manipulations can activate biogenetic triggers […] ↓ Read the rest of this entry…
English